DIATHEVA - Biomanufacturing of innovative diagnostics and reagents

Library / Papers / Tumor markers

Tumor markers

Documents

No Title File Type Download
1 Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system. Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system.
2 The expression and modulation of CEACAM1 and tumor cell transformation. The expression and modulation of CEACAM1 and tumor cell transformation.
3 CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors
4 Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein
5 CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
6 Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system
7 Generation of Human Single-chain Antibody to the CD99 Cell Surface Determinant Specifically Recognizing Ewing’s Sarcoma Tumor Cells Generation of Human Single-chain Antibody to the CD99 Cell Surface Determinant Specifically Recognizing Ewing’s Sarcoma Tumor Cells
8 CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
9 Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma
10 The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro
11 Oral Squamomelanocytic Tumour in a Dog: a Unique Biphasic Cancer Oral Squamomelanocytic Tumour in a Dog: a Unique Biphasic Cancer
12 Novel Immunomodulatory Pathways in the Immunoglobulin Superfamily Novel Immunomodulatory Pathways in the Immunoglobulin Superfamily
Company certified
ISO9001
Certified N.
IT05/0576
info@diatheva.com
Phone (+39) 0721 830605
Fax (+39) 0721 837154
 
website netcompany
P.IVA.01403060427

By navigating this website you provide your agreement to the use of cookies, which we use to improve your navigation experience and for statistical analysis. Read our Cookie Policy to learn more

Your Shopping Cart

 x 
Cart empty